Dechert advised Olgram on the deal. Olgram, a French biotech company that develops algae-based anti-infectives, completed its €1.5 million fundraising. The investors include bpifrance, the Brittany...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here